Top1000 Scholar

Scholarly Index

David R. Spigel

Sarah Cannon; 77,759 total citations; 826 total publications; best world rank #42

Sarah Cannon

77,759Total citations
826Total publications
97H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Lung Cancer Treatments and MutationsLifetime50US 3199.82
Lung Cancer Research StudiesLifetime42US 2599.78
Cancer Immunotherapy and BiomarkersLifetime85US 4999.78
Lung Cancer Diagnosis and TreatmentLifetime108US 5799.62
Neuroendocrine Tumor Research AdvancesLifetime101US 4899.49
Peptidase Inhibition and AnalysisLifetime137US 6599.35
Cancer therapeutics and mechanismsLifetime109US 6499.27
Colorectal Cancer Treatments and StudiesLifetime182US 9099.35
Cancer Genomics and DiagnosticsLifetime372US 22199.31
Cancer Treatment and PharmacologyLifetime704US 34798.14
CAR-T cell therapy researchLifetime910US 52497.67
Cancer Diagnosis and TreatmentLifetime770US 34696.49
HER2/EGFR in Cancer ResearchLifetime771US 34396.93
Economic and Financial Impacts of CancerLifetime415US 26895.68
PARP inhibition in cancer therapyLifetime897US 37991.38
Lung Cancer Treatments and Mutations2021-202568US 3099.55
Cancer Immunotherapy and Biomarkers2021-2025184US 7399.30
Lung Cancer Research Studies2021-202568US 2698.93
Cancer Genomics and Diagnostics2021-2025198US 9498.43
Colorectal Cancer Treatments and Studies2021-2025226US 7697.03
Lung Cancer Diagnosis and Treatment2021-2025349US 10996.33
Peptidase Inhibition and Analysis2021-2025196US 5795.66
Neuroendocrine Tumor Research Advances2021-2025309US 8493.89
Gastric Cancer Management and Outcomes2021-2025862US 14694.10
HER2/EGFR in Cancer Research2021-2025569US 20090.82
Cancer therapeutics and mechanisms2021-2025313US 7985.27
Advanced Breast Cancer Therapies2021-2025840US 28985.10
Chemical Reactions and Isotopes2021-2025322US 4762.73